Cargando…
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
As a consequence of an increasingly aging population, the number of people affected by neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and Huntington's disease, is rapidly increasing. Although the etiology of these diseases has not been completely defined...
Autores principales: | Cassano, Tommaso, Calcagnini, Silvio, Pace, Lorenzo, De Marco, Federico, Romano, Adele, Gaetani, Silvana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288380/ https://www.ncbi.nlm.nih.gov/pubmed/28210207 http://dx.doi.org/10.3389/fnins.2017.00030 |
Ejemplares similares
-
Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
por: Cassano, Tommaso, et al.
Publicado: (2019) -
From Obesity Resistance to Obesity Prediction and Prevention?
por: Gaetani, Silvana, et al.
Publicado: (2016) -
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020) -
Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues
por: Gallelli, Cristina Anna, et al.
Publicado: (2018) -
PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer’s Disease
por: Cassano, Tommaso, et al.
Publicado: (2023)